Detalhe da pesquisa
1.
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.
Immunity
; 55(9): 1732-1746.e5, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961317
2.
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(4): 319-332, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511784
3.
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Future Oncol
; 20(12): 717-726, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088119
4.
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region.
Eur J Haematol
; 111(5): 748-756, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565648
5.
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
Eur J Haematol
; 111(5): 715-721, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501508
6.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(8): 1031-1043, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810754
7.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Mol Med
; 28(1): 20, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135470
8.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
9.
Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?
Scand J Immunol
; 95(4): e13153, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35244285
10.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Haematologica
; 106(1): 87-97, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974198
11.
Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells.
Prostaglandins Other Lipid Mediat
; 156: 106575, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34116165
12.
Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Handb Exp Pharmacol
; 269: 75-99, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490515
13.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Br J Haematol
; 191(3): 426-432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779190
14.
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report.
Br J Haematol
; 189(4): 689-693, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31994178
15.
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion.
Haematologica
; 106(9): 2354-2363, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054121
16.
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blood
; 140(22): 2403-2407, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150168
17.
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia.
Haematologica
; 109(2): 646-651, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646668
18.
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Haematologica
; 104(4): 797-804, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467205
19.
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes.
Br J Haematol
; 183(2): 212-224, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125946
20.
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Br J Haematol
; 182(4): 504-512, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873072